As part of the acquisition, more than 130associates from Labindia have transferred to Leica Microsystems to, as Leicanotes, "sustain continuity for existing customers who will continue to benefitfrom Labindia's wide experience of their needs and applications." Leica callsthe acquisition "a natural culmination of a long and fruitful partnership" thatalso supports Leica's strategy to expand its operations in India.
"Leica Microsystems' expansion of its commercialoperations in India creates extended opportunities for interaction,collaboration and innovation to benefit all of our customers in the lifesciences, industrial laboratories and hospitals for both diagnostics and surgery,"explains Arnd Kaldowski, president of Leica. "This acquisition will enablecloser contact with our customers so that we can better support them in theirday-to-day work."
"We are convinced that at this point in time thisagreement is a logical further step in the long history of close cooperationbetween Labindia and Leica Microsystems and that it will be beneficial to allour customers," says Vijay Bibikar, director of Labindia. He further assurescustomers and potential future customers that he plans to ensure "the globalhigh standards of Leica sales and support will be available to our customers inIndia as well" and adds that he plans to strengthen offerings in the Indianmarket and increase investments in India to better help support clients'professional needs.
At the global level, Leica Microsystems isorganized in four divisions: the Life Science Division, Industry Division,Biosystems Division and Medical Division. Leica Microsystems' BiosystemsDivision, also known as Leica Biosystems, offers histopathology laboratories whatit calls "the most extensive product range with appropriate products for eachwork step in histology and for a high level of productivity in the working processesof the entire laboratory." Leica is represented in more than 100 countries with12 manufacturing facilities in seven countries, sales and service organizationsin 19 countries and an international network of dealers.
In similar news, Labindia had also recently soldits mass spectrometry business to AB Sciex, which the company says was, likethe deal with Leica, "a natural outcome" of supply arrangements AB Sciex hadwith it. Labindia had been supplying AB Sciex mass spectrometry instruments tothe Indian market for the past 15 years and the acquisition included atransition of personnel over to AB Sciex in addition to facilities. Like Leica,AB Sciex seeks to create new opportunities for partnerships and development byexpanding into India.
